Effect of Esketamine on Postoperative Analgesia and Postoperative Delirium in Elderly Patients Undergoing Gastrointestinal Surgery
Overview
Authors
Affiliations
Objective: To investigate the analgesic effect of esketamine combined with low-dose sufentanil in elderly patients after gastrointestinal surgery, and whether the anti-inflammatory effect of esketamine is involved in the mechanism of postoperative delirium.
Method: We enrolled sixty elderly patients (age ≥ 65 years old, American Society of Anesthesiologists (ASA) grade I-III) who underwent gastrointestinal surgery. Patients were randomly assigned to Group C (control group) who received sufentanil 2 ug/kg, and Group E (experimental group) who received sufentanil 1.5 ug/kg + esketamine 1 mg/kg, with 30 patients in each group. All patients underwent total intravenous anesthesia during the surgery and were connected to a patient-controlled intravenous analgesia (PCIA) pump after surgery. The primary outcome was the evaluation of pain at 4, 24, 48 h after surgery which was evaluated by NRS scores. In secondary outcomes, inflammation was assessed by measuring IL-6 levels using ELISA. The postoperative delirium and the occurrence of adverse reactions were observed on the 1st and 3rd day after surgery.
Results: The NRS scores at 4, 24, and 48 h after surgery in the experimental group [(4.53 ± 1.22), (3.46 ± 0.73), (1.37 ± 0.99)] were lower than that in the control group [(5.23 ± 1.16), (4.46 ± 0.77), (2.13 ± 0.78)] (P < 0.05). The concentration of serum IL-6 in the experimental group at 24 and 48 h after operation [(15.96 ± 4.65), (11.8 ± 3.24)] were lower than that in the control group [(23.07 ± 4.86), (15.41 ± 4.01)] (P < 0.05); the incidence of postoperative delirium in the experimental group was less than that in the control group (P < 0.05); there was no significant difference in the incidence of postoperative nausea and vomiting between the two groups (P > 0.05), and neither group had nightmares or delirium.
Conclusion: Esketamine may enhance postoperative pain management compare with sufentanil, and esketamine has anti-inflammatory effects that reduce the incidence of postoperative delirium.
Trial Registration: Full name of the registry: Chinese Clinical Trial Registry.
Trial Registration Number: ChiCTR2300072374. Date of registration:2023/06/12.
Shao C, Huang Q, Huang W, Lu Y, Zhang D, Feng Q BMJ Open. 2025; 15(3):e092159.
PMID: 40054869 PMC: 11891525. DOI: 10.1136/bmjopen-2024-092159.
Huan C, Zhang T, Jiang Y, He S, Jin J Drug Des Devel Ther. 2025; 19():229-238.
PMID: 39830786 PMC: 11740904. DOI: 10.2147/DDDT.S502938.
Esketamine and neurocognitive disorders in adult surgical patients: a meta-analysis.
Lin X, Liu X, Huang H, Xu X, Zhang T, Gao J BMC Anesthesiol. 2024; 24(1):448.
PMID: 39639216 PMC: 11619128. DOI: 10.1186/s12871-024-02803-3.
Li X, He X, Li M, Gu X, Wang P, Wu Y BMC Oral Health. 2024; 24(1):1460.
PMID: 39623402 PMC: 11610279. DOI: 10.1186/s12903-024-05273-8.
Zhang W, Wang D, Li S, Chen Y, Bi C BMC Anesthesiol. 2024; 24(1):442.
PMID: 39609668 PMC: 11603621. DOI: 10.1186/s12871-024-02833-x.